Illumina Customers 'Back to Work' as Q4 Sequencing Consumables Recover, MiSeq Drives Growth | GenomeWeb

By Monica Heger

This story was originally published Feb. 8.

Illumina's CEO Jay Flatley said this week that the fourth quarter of 2011 could be best characterized as customers "getting back to work" following a surplus in sequencing throughput that led to disappointing consumables sales in the third quarter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.